A 38-year-old Primigravida who is pregnant after IVF , has a sonogram performed that shows Nuchal translucency of 5 mm at 12wks 4 days gestation. Which of the following is the only true statement?
## **Core Concept**
The nuchal translucency (NT) scan is a critical component of first-trimester screening for aneuploidy, particularly for Down syndrome (Trisomy 21), and also serves as a marker for potential cardiac and other structural anomalies. It measures the thickness of the fluid-filled space at the back of the fetus's neck. An increased nuchal translucency is associated with a higher risk of aneuploidy and structural heart defects.
## **Why the Correct Answer is Right**
An increased nuchal translucency of 5 mm at 12 weeks and 4 days gestation indicates a higher risk for aneuploidy and congenital heart defects. This measurement is considered increased because, typically, a nuchal translucency of less than 3.5 mm is considered normal at this gestational age. The exact cut-off can vary slightly by specific guidelines and gestational age, but 5 mm is generally considered elevated. This finding warrants further diagnostic testing, such as chorionic villus sampling (CVS) or amniocentesis, to assess for chromosomal abnormalities and detailed ultrasound examination to evaluate fetal anatomy, particularly the heart.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on what Option A states, it's not possible to directly address its incorrectness. However, if it suggests that an NT of 5 mm is within normal limits or doesn't require further testing, it would be incorrect because an NT of 5 mm is considered increased.
- **Option B:** Similarly, without specifics, if Option B provides an incorrect management strategy or risk assessment for an NT of 5 mm, it would be wrong based on the established guidelines for managing increased nuchal translucency.
- **Option C:** If Option C provides an inaccurate statement regarding the implications of increased nuchal translucency, such as not being associated with an increased risk of aneuploidy or structural anomalies, it would be incorrect.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that an increased nuchal translucency thickness is not only a marker for aneuploidy but also for potential cardiac anomalies. Therefore, a detailed fetal echocardiogram is often recommended for fetuses with an increased nuchal translucency, even if the karyotype is normal.
## **Correct Answer: D.**